| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in NBIX over the last quarter tilts toward selling: insiders offloaded a net 6,541 shares worth roughly $1.1M.
Classified under Pharmaceuticals (Health Care sector), NBIX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 517.8K | $80.89M | - | |
| CEO | 154.7K | $24.17M | - | |
| Other | 67.3K | $10.51M | - | |
| Other | 56.8K | $8.87M | - | |
| CFO | 42.8K | $6.73M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2024 | Benevich Eric62 | Chief Commercial Officer | Sale+OE | 75,000 | $134.69 | $10,101,607.50 | -64.9% | +4.3% | -12.7% | |
| Feb 27, 2024 | Norwalk Leslie V64 | Director | Sale+OE | 8,000 | $135.67 | $1,085,388.00 | -100% | +3.3% | -13.6% | |
| Feb 20, 2024 | Pops Richard F57 | Director | Sale+OE | 15,000 | $132.47 | $1,987,047.00 | -33.7% | +6.8% | -13.9% | |
| Feb 13, 2024 | Boyer David W.51 | Chief Corp. Affairs Officer | Sell | 1,811 | $133.07 | $240,995.73 | -27.0% | +1.7% | -12.4% | |
| Feb 13, 2024 | Abernethy Matt57 | Chief Financial Officer | Sell | 1,352 | $132.85 | $179,611.58 | -4.1% | +1.7% | -12.4% | |
| Feb 13, 2024 | Benevich Eric62 | Chief Commercial Officer | Sell | 1,098 | $133.01 | $146,050.36 | -2.6% | +1.7% | -12.4% | |
| Feb 13, 2024 | Cooke Julie59 | Chief Human Resources Officer | Sell | 796 | $133.04 | $105,902.15 | -4.2% | +1.7% | -12.4% | |
| Feb 13, 2024 | Delaet Ingrid66 | Chief Regulatory Officer | Sell | 716 | $133.03 | $95,252.77 | -8.7% | +1.7% | -12.4% | |
| Feb 13, 2024 | Gano Kyle54 | Chief Business Development Off | Sell | 1,352 | $132.89 | $179,673.63 | -1.0% | +1.7% | -12.4% | |
| Feb 13, 2024 | Gorman Kevin Charles55 | Chief Executive Officer | Sell | 2,832 | $133.02 | $376,700.46 | -0.5% | +1.7% | -12.4% |